Business
MediPharm Labs Sets Date to Report First Quarter 2025 Financial Results
MediPharm Labs Sets Date to Report First Quarter 2025 Financial Results Canada NewsWire...
About this update from Medipharm Labs Corp.
[{"type":"text","content":"\n\n\n\n MediPharm Labs Sets Date to Report First Quarter 2025 Financial Results\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnml40{\nMARGIN-LEFT:3.33em !IMPORTANT\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n TORONTO\n \n\n ,\n \n\n May 9, 2025\n \n\n /CNW/ -\n \n MediPharm Labs Corp.\n \n (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (\"MediPharm\", \"MediPharm Labs\" or the \"Company\") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its first quarter financial results for the period ended March 31, 2025, before markets open on Wednesday, May 14, 2025.\n \n\n\n\n\n\n\n\n\n MediPharm Labs executive management team will also host a conference call and webcast on Wednesday, May 14, 2025, at 10:00 a.m. (Eastern time) to discuss the Company's financial results.\n \n\n\n Conference Call Dial in Details:\n \n\n\n North America Toll-Free: (888) 330-2454\n \n\n International Toll: +1 (240) 789-2714\n \n\n Conference ID: 4921762\n \n\n Participants are asked to dial in approximately 15 minutes before the start of the call.\n \n\n\n Webcast:\n \n\n\n A webcast will be available by visiting the following link\n \n\n\n here\n \n\n\n .\n \n\n For those who are unable to participate on the live conference call or webcast, a replay will be available at\n \n\n\n https://www.medipharmlabs.com/investors\n \n\n\n approximately one day after completion of the call.\n \n\n\n About MediPharm Labs\n \n\n\n Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities for delivery of pure, trusted and precision-dosed cannabis products for its customers. MediPharm Labs develops, form...